Di̇lek Erdem

558 total citations
38 papers, 267 citations indexed

About

Di̇lek Erdem is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Di̇lek Erdem has authored 38 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Di̇lek Erdem's work include Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Di̇lek Erdem is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Di̇lek Erdem collaborates with scholars based in Türkiye, United States and United Kingdom. Di̇lek Erdem's co-authors include İdris Yücel, Tekin Akpolat, Melda Dilek, Güzin Gönüllü, Sabri Demircan, Şeyda Gündüz, Yıldız Okuturlar, Sema Sezgin Göksu, Meral Günaldı and Mustafa Yıldırım and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Di̇lek Erdem

34 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Di̇lek Erdem Türkiye	10	122	87	43	42	35	38	267
Laura Mazilu Romania	10	71 0.6×	76 0.9×	29 0.7×	66 1.6×	24 0.7×	47	325
Chaoyi Zheng United States	10	123 1.0×	95 1.1×	55 1.3×	64 1.5×	15 0.4×	21	352
Di Meng China	13	42 0.3×	135 1.6×	46 1.1×	38 0.9×	60 1.7×	25	402
Shirley Thomas United States	6	169 1.4×	53 0.6×	10 0.2×	64 1.5×	30 0.9×	10	311
Arian Mansur United States	12	60 0.5×	66 0.8×	27 0.6×	53 1.3×	19 0.5×	56	333
Yasuhiro Toyoda Japan	10	168 1.4×	76 0.9×	18 0.4×	143 3.4×	30 0.9×	42	395
Limor Helpman Israel	16	122 1.0×	192 2.2×	63 1.5×	54 1.3×	36 1.0×	71	658
Amelia Jernigan United States	13	146 1.2×	155 1.8×	44 1.0×	52 1.2×	48 1.4×	47	462
Leonardo Rapacchietta Italy	7	68 0.6×	61 0.7×	72 1.7×	146 3.5×	22 0.6×	7	285
Jim Tiernan United Kingdom	10	150 1.2×	266 3.1×	78 1.8×	87 2.1×	9 0.3×	33	429

Countries citing papers authored by Di̇lek Erdem

Since Specialization

Citations

This map shows the geographic impact of Di̇lek Erdem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di̇lek Erdem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di̇lek Erdem more than expected).

Fields of papers citing papers by Di̇lek Erdem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di̇lek Erdem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di̇lek Erdem. The network helps show where Di̇lek Erdem may publish in the future.

Co-authorship network of co-authors of Di̇lek Erdem

This figure shows the co-authorship network connecting the top 25 collaborators of Di̇lek Erdem. A scholar is included among the top collaborators of Di̇lek Erdem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di̇lek Erdem. Di̇lek Erdem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arslan, Çağatay, Fatih Selçukbırıcık, Ömer Fatih Ölmez, et al.. (2024). Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Medicina. 60(12). 2103–2103.

Tural, Deniz, Fatih Selçukbırıcık, Ömer Fatih Ölmez, et al.. (2024). Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer. Clinical Genitourinary Cancer. 22(6). 102228–102228.

Erdem, Di̇lek, et al.. (2023). Prenatal Attachment and Mental Well-Being Among Expectant Fathers Amidst COVID-19: A Cross-Sectional Study. Cureus. 15(9). e44806–e44806. 1 indexed citations

Erdem, Di̇lek, et al.. (2023). Maternal prenatal attachment during the COVID-19 pandemic: exploring the roles of pregnancy-related anxiety, risk perception, and well-being. Archives of Women s Mental Health. 26(5). 651–658. 2 indexed citations

Erdem, Di̇lek, et al.. (2022). Discoidin domain receptor 1 as a promising biomarker for high-grade gliomas. Journal of Cancer Research and Therapeutics. 19(Suppl 1). S285–S293. 1 indexed citations

Tural, Deniz, Çağatay Arslan, Fatih Selçukbırıcık, et al.. (2022). Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice. Clinical Genitourinary Cancer. 21(3). 334–341. 2 indexed citations

Bılıcı, Ahmet, Ömer Fatih Ölmez, Ahmet Sezer, et al.. (2022). Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).. Journal of Clinical Oncology. 40(16_suppl). e12610–e12610. 2 indexed citations

Şendur, Mehmet Alı Nahıt, Burcu Çakar, Sercan Aksoy, et al.. (2021). 124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey. Annals of Oncology. 32. S74–S74. 1 indexed citations

Gündüz, Şeyda, Di̇lek Erdem, Deniz Can Güven, et al.. (2021). Ixabepilone in Metastatic Breast Cancer: Real-World Experience. 7(3). 85–90. 2 indexed citations

10.

Erdem, Di̇lek, et al.. (2019). Evaluation of the Relationship between eNOS and Breast Cancer. DergiPark (Istanbul University). 2 indexed citations

11.

Günaldı, Meral, Di̇lek Erdem, Sema Sezgin Göksu, et al.. (2016). Platelet Distribution Width as a Predictor of Metastasis in Gastric Cancer Patients. Journal of Gastrointestinal Cancer. 48(4). 341–346. 20 indexed citations

12.

Topgül, Koray, Mehmet Çetinkaya, Naci̇ye Çiğdem Arslan, et al.. (2015). Cytoreductive surgery (SRC) for treatment of peritoneal carcinomatosis and hyperthermic ıntraperitoneal chemotherapy (HIPEC): Our initial experience and technical details. Turkish Journal of Surgery. 31(3). 138–47. 3 indexed citations

13.

Erdem, Di̇lek, Hasan Alaçam, Yüksel Bek, et al.. (2014). The Relationship of T Helper-2 Pathway Components Interleukin-4, Interleukin-10, Immunoglobulin E, and Eosinophils with Prognostic Markers in Non-Hodgkin Lymphoma: A Case-Control Study. Turkish Journal of Hematology. 31(4). 381–387. 1 indexed citations

14.

Erdem, Di̇lek, et al.. (2012). Brain Metastases in Gastrointestinal Cancers. Annals of Oncology. 23. ix221–ix222. 1 indexed citations

15.

Erdem, Di̇lek, et al.. (2012). Baseline lymphopenia as a prognostic marker for colorectal carcinoma.. Journal of Clinical Oncology. 30(15_suppl). e14107–e14107. 1 indexed citations

16.

Gönüllü, Güzin, et al.. (2011). Electrocardiographic findings of palonosetron in cancer patients. Supportive Care in Cancer. 20(7). 1435–1439. 40 indexed citations

17.

Akpolat, Tekin, et al.. (2009). Home sphygmomanometers: validation versus accuracy. Blood Pressure Monitoring. 14(1). 26–31. 32 indexed citations

18.

Erdem, Di̇lek, et al.. (2009). Accuracy of Sphygmanometers at Pharmacies. Kidney & Blood Pressure Research. 32(4). 231–234. 8 indexed citations

19.

Yapıcı, Oktay, et al.. (2007). Acute Complete Splenic Infarction in a Patient with Hirschsprung’s Disease and Literature Review of Complete Splenic Infarction. Pathophysiology of Haemostasis and Thrombosis. 36(2). 102–104. 2 indexed citations

20.

Aksaz, Erol, et al.. (2002). TNF-alpha levels in patients with malignant tumors after hyperthermic isolated regional perfusion.. PubMed. 21(4). 489–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact